MITOS THERAPEUTICS Trademark

Trademark Overview

On Monday, March 25, 2024, a trademark application was filed for MITOS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MITOS THERAPEUTICS trademark a serial number of 79396791. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Thursday, October 16, 2025. This trademark is owned by Mitos Therapeutics Inc.. The MITOS THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

RNA interference technology research; drug discovery services; pharmaceutical research and development; scientific research in the field of pharmacy; technical research in the field of pharmaceutical studies; pharmaceutical drug development services; providing information on the testing, inspection and research of medical products; scientific research in the nature of conducting clinical trials for others; laboratory research services relating to dermatology; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs.
mitos therapeutics

General Information

Serial Number79396791
Word MarkMITOS THERAPEUTICS
Filing DateMonday, March 25, 2024
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateThursday, October 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesRNA interference technology research; drug discovery services; pharmaceutical research and development; scientific research in the field of pharmacy; technical research in the field of pharmaceutical studies; pharmaceutical drug development services; providing information on the testing, inspection and research of medical products; scientific research in the nature of conducting clinical trials for others; laboratory research services relating to dermatology; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMitos Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Thursday, June 6, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, June 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 10, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, October 2, 2024ASSIGNED TO EXAMINER
Wednesday, October 9, 2024NON-FINAL ACTION WRITTEN
Thursday, October 10, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 15, 2024REFUSAL PROCESSED BY MPU
Tuesday, October 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, November 17, 2024REFUSAL PROCESSED BY IB
Friday, April 11, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 11, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 11, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 11, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 11, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, April 11, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 14, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 15, 2025SUSPENSION LETTER WRITTEN
Tuesday, April 15, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, April 15, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 16, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 5, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, November 5, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, November 22, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Related Keywords

therapeutics mitos research services pharmaceutical scientific field inspection development testing drug laboratory